Genmab A (GMAB) Current Leases (2019 - 2026)
Genmab A (GMAB) posted Current Leases of $125.0 million for Q1 2026, down 6.72% on a QoQ basis from $134.0 million in Q4 2025, and down 3.1% year-over-year from $129.0 million in Q1 2025.
Genmab A (GMAB) Current Leases (2019 - 2026) Analysis & Trends
Genmab A's Current Leases history runs 6 years deep, the most recent figure standing at $125.0 million for Q1 2026.
- Quarterly Current Leases fell 3.1% year-over-year to $125.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125.0 million (down 3.1% YoY) and the FY2025 annual result came in at $134.0 million, up 930.77% from the prior year.
- Current Leases was $125.0 million for Q1 2026 at Genmab A, down from $134.0 million in the prior quarter.
- Across five years, Current Leases topped out at $134.0 million in Q4 2025 and bottomed at $13.0 million in Q4 2023.
- A 4-year average of $96.0 million and a median of $126.0 million in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2025 — Current Leases surged 930.77% — and 2026, when it declined 3.1%.
- Genmab A's Current Leases stood at $13.0 million in 2023, then changed by 0.0% to $13.0 million in 2024, then jumped by 930.77% to $134.0 million in 2025, then decreased by 6.72% to $125.0 million in 2026.
- Business Quant data shows GMAB's Current Leases at $125.0 million in Q1 2026, $134.0 million in Q4 2025, and $126.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Genmab A | 1.89 Bn | 366.92 Mn | 831.00 Mn | 125.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125.00 Mn |
| Dec 31, 2025 | 134.00 Mn |
| Sep 30, 2025 | 126.00 Mn |
| Jun 30, 2025 | 132.00 Mn |
| Mar 31, 2025 | 129.00 Mn |
| Dec 31, 2024 | 13.00 Mn |
| Dec 31, 2023 | 13.00 Mn |
| Sep 30, 2020 | 295.00 |
| Dec 31, 2019 | 155.00 |
| Sep 30, 2019 | 157.61 Mn |